Status:
UNKNOWN
Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment
Lead Sponsor:
Bayside Health
Collaborating Sponsors:
Baker Heart and Diabetes Institute
The Alfred
Conditions:
Type 2 Diabetes
Obesity
Eligibility:
MALE
19-35 years
Phase:
NA
Brief Summary
Obesity is epidemic in Australia, and current preventative strategies have had limited success in alleviating this health crisis. While numerous options are available for treatment of obesity, most do...
Eligibility Criteria
Inclusion
- Males aged 19 - 35 years
- Free of overt coronary disease (on history, medical examination and ECG)
- Unmedicated
- No major illness
- BMI \<27 kg/m2
Exclusion
- Unable to give informed consent
- Smokers
- Participant in research projects involving ionising radiation within the past 5 years.
- Claustrophobia
- Fasting plasma glucose \> 6.0 mmol/L
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT02236962
Start Date
April 1 2012
Last Update
September 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3004